Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.047,09
0,23%
NASDAQ Composite
15.796,72
0,89%
Bitcoin
57.391,48
-5,30%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Spruce Biosciences Inc (SPRB) Spruce Biosciences Inc (SPRB) Notizie

Spruce Biosciences Inc

SPRB
0,7275
0,0195 (2,75%)
Ultimo aggiornamento: 21:32:40
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:05BWSpruce Biosciences Announces Additional Poster Presentation..
22/4/202422:05BWSpruce Biosciences Announces Upcoming Poster Presentation at..
13/3/202421:08BWSpruce Biosciences Reports Full Year 2023 Financial Results..
13/3/202421:01BWSpruce Biosciences Announces Topline Results from..
07/3/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202422:05BWSpruce Biosciences to Present at the Oppenheimer 34th Annual..
22/1/202414:00BWSpruce Biosciences Completes Enrollment in CAHmelia-204..
08/1/202414:00EDGAR2Form 8-K - Current report
05/1/202414:00BWSpruce Biosciences Reports Baseline Characteristics from..
04/1/202414:00BWSpruce Biosciences Provides Clinical Program Updates and..
03/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202302:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202302:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/11/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202322:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:09EDGAR2Form 8-K - Current report
13/11/202322:05BWSpruce Biosciences Reports Third Quarter 2023 Financial..
02/11/202321:05BWSpruce Biosciences to Participate in the Jefferies London..
18/10/202314:00BWSpruce Biosciences Completes Target Enrollment of..
28/8/202322:00BWSpruce Biosciences to Participate in the H.C. Wainwright..
14/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:12EDGAR2Form 8-K - Current report
14/8/202322:00BWSpruce Biosciences Reports Second Quarter 2023 Financial..
06/7/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202322:00BWSpruce Biosciences Announces Acceptance of Abstract for..
25/5/202314:00BWSpruce Biosciences Appoints Percival Barretto-Ko to Board of..
24/5/202322:05BWSpruce Biosciences to Participate in the Jefferies..
22/5/202315:30BWSpruce Biosciences Honored at CARES Foundation 15th Annual..
15/5/202314:00BWSpruce Biosciences Reports First Quarter 2023 Financial..
04/5/202322:05BWSpruce Biosciences to Present Findings on Retrospective..
02/5/202322:05BWSpruce Biosciences to Participate in May Investor..
Apertura: 0,73 Min: 0,7101 Max: 0,7507
Chiusura: 0,708

La tua Cronologia

NASDAQ
SPRB
Spruce Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network